ICOS to Participate in Upcoming Investment Conference
October 31 2005 - 8:03PM
Business Wire
ICOS Corporation (Nasdaq:ICOS) announced today that it will
participate in the Credit Suisse First Boston Healthcare Conference
on Wednesday, November 16, 2005. The presentation, which may
include a discussion of financial guidance and future plans, will
be webcast. -0- *T Credit Suisse First Boston Healthcare Conference
Presentation Date: November 16, 2005 Time: 3:30 p.m. EST Speaker:
Gary L. Wilcox, Ph.D., Executive Vice President, Operations *T A
webcast of this ICOS presentation will be available in real-time
and a replay will be available through November 23, 2005. The
webcast can be accessed through the ICOS Web site, www.icos.com,
Investor -- Events section. Additional information on ICOS,
including past press releases, is also available at www.icos.com.
About ICOS Corporation: ICOS Corporation, a biotechnology company
headquartered in Bothell, Washington, is dedicated to bringing
innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS
is marketing its first product, Cialis(R) (tadalafil), for the
treatment of erectile dysfunction. ICOS is working to develop
treatments for serious unmet medical conditions such as pulmonary
arterial hypertension, benign prostatic hyperplasia, hypertension,
cancer and inflammatory diseases. This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements involve risks and uncertainties that could cause ICOS'
results and the timing of certain events to differ materially from
those discussed in the forward-looking statements, including risks
associated with product commercialization, manufacturing
activities, clinical development, regulatory approvals,
intellectual property claims and litigation and other risks
detailed in ICOS' latest Quarterly Report on Form 10-Q and its
other SEC filings.
Icos (NASDAQ:ICOS)
Historical Stock Chart
From May 2024 to Jun 2024
Icos (NASDAQ:ICOS)
Historical Stock Chart
From Jun 2023 to Jun 2024